Search for: "Sanofi"
Results 81 - 100
of 1,197
Sort by Relevance
|
Sort by Date
31 Jul 2023, 1:18 am
Interestingly, the US Supreme Court in the recent decision on enablement in Amgen v Sanofi also took great pains to emphasise that the law of enablement of broadly claimed inventions was originally derived from, and continues to apply, to the mechanical field (IPKat). [read post]
28 Jul 2023, 8:26 am
However, it follows a similar action filed in May by Lake County, Illinois in which the County accuses Eli Lilly, Novo Nordisk, Sanofi, Express Scripts, and OptumRx are accused of violating the state's Consumer Fraud Act and the RICO Act. [read post]
23 Jul 2023, 9:53 pm
Sanofi, where the Supreme Court addressed the enablement requirement for patent claims directed to antibodies.... [read post]
20 Jul 2023, 3:44 am
This is the second post considering the Court of Appeal decision on plausibility in Sandoz v BMS ([2023] EWCA Civ 472), in the context of the Enlarged Board of Appeal decision in G 2/21. [read post]
20 Jul 2023, 1:42 am
This Kat took the enforced confinement of a rainy summer weekend to finally delve deeper into one of the key patent decisions from the UK courts this year. [read post]
15 Jul 2023, 6:00 am
Sanofi NG 598/2 23 5/18/23 21-869 Andy Warhol Foundation for Visual Arts, Inc. v. [read post]
15 Jul 2023, 6:00 am
Sanofi NG 598/2 23 5/18/23 21-869 Andy Warhol Foundation for Visual Arts, Inc. v. [read post]
13 Jul 2023, 5:01 am
Sanofi. [read post]
9 Jul 2023, 8:40 pm
Sanofi regarding the sufficiency of disclosure needed to satisfy the statutory enablement requirement under 35 US.C. [read post]
3 Jul 2023, 3:00 am
Sanofi to require that the full scope of the claims must be enabled. [read post]
26 Jun 2023, 6:59 am
This version of insulin is expected to be interchangeable with popular brand-name insulins – Sanofi’s Lantus, Eli Lilly’s Humalog and Novo Nordisk’s Novolog. [read post]
26 Jun 2023, 3:38 am
The patents concerned are the same patent family that was successfully challenged before the US Supreme Court in Amgen v Sanofi, which you can read about here from Rose Hughes. [read post]
22 Jun 2023, 4:45 am
Sanofi upholds the Federal Circuit’s longstanding requirement to enable the full scope of a claimed invention. [read post]
22 Jun 2023, 4:45 am
Sanofi upholds the Federal Circuit’s longstanding requirement to enable the full scope of a claimed invention. [read post]
21 Jun 2023, 4:05 pm
Sanofi, the implications of artificial intelligence (AI) for patenting, and ethics pitfalls practitioners may face as a result of AI use. [read post]
21 Jun 2023, 4:05 pm
Sanofi, the implications of artificial intelligence (AI) for patenting, and ethics pitfalls practitioners may face as a result of AI use. [read post]
15 Jun 2023, 2:20 pm
., Sanofi-Aventis Deutschland GmbH v. [read post]
10 Jun 2023, 4:02 pm
This approach is consistent with existing case law.Rose mentioned that the recent US Supreme Court decision Amgen v Sanofi (No. 21-757) was also a good decision. [read post]
9 Jun 2023, 8:20 am
Sanofi for patents come to mind – the Jack Daniel’s court is much more assertive than it usually is in this area in offering bold and unqualified basic principles as a basis for its decision. [read post]
31 May 2023, 9:43 am
Amgen sued Sanofi for infringement and Sanofi counterclaimed that Amgen's patents were invalid for lack of enablement. [read post]
